SE8305667D0 - Adenocarcinoma related new antigenic determinants and antibodies specific thereto, processes for their preparation and reagent systems pertaining to them - Google Patents

Adenocarcinoma related new antigenic determinants and antibodies specific thereto, processes for their preparation and reagent systems pertaining to them

Info

Publication number
SE8305667D0
SE8305667D0 SE8305667A SE8305667A SE8305667D0 SE 8305667 D0 SE8305667 D0 SE 8305667D0 SE 8305667 A SE8305667 A SE 8305667A SE 8305667 A SE8305667 A SE 8305667A SE 8305667 D0 SE8305667 D0 SE 8305667D0
Authority
SE
Sweden
Prior art keywords
antigenic determinants
processes
preparation
antibodies specific
reagent systems
Prior art date
Application number
SE8305667A
Other languages
English (en)
Other versions
SE8305667L (sv
Inventor
A Bartorelli
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE8305667D0 publication Critical patent/SE8305667D0/sv
Publication of SE8305667L publication Critical patent/SE8305667L/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE8305667A 1983-06-23 1983-10-14 Adenokarcinomrelaterade nya antigena determinanter och antikroppar som er specifika for dessa, forfarande for deras framstellning samt reagenssystem henforande sig till dem SE8305667L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838317022A GB8317022D0 (en) 1983-06-23 1983-06-23 Adenocarcinoma related new antigenic determinants

Publications (2)

Publication Number Publication Date
SE8305667D0 true SE8305667D0 (sv) 1983-10-14
SE8305667L SE8305667L (sv) 1984-12-24

Family

ID=10544654

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305667A SE8305667L (sv) 1983-06-23 1983-10-14 Adenokarcinomrelaterade nya antigena determinanter och antikroppar som er specifika for dessa, forfarande for deras framstellning samt reagenssystem henforande sig till dem

Country Status (13)

Country Link
JP (1) JPS6018765A (sv)
AU (1) AU2017183A (sv)
BE (1) BE899484A (sv)
DE (1) DE3337465A1 (sv)
DK (1) DK476083A (sv)
FI (1) FI833742A (sv)
FR (1) FR2548901A1 (sv)
GB (1) GB8317022D0 (sv)
IT (1) IT1194429B (sv)
NL (1) NL8303571A (sv)
NO (1) NO833756L (sv)
SE (1) SE8305667L (sv)
ZA (1) ZA837673B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2589630B2 (ja) * 1992-06-12 1997-03-12 ゼニヤ海洋サービス株式会社 砂防ダム用放水装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086217A (en) * 1976-03-03 1978-04-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0044167A3 (en) * 1980-07-14 1982-04-21 The Regents Of The University Of California Antibody targeted cytotoxic agent
EP0072902B1 (de) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
DE3230299A1 (de) * 1982-08-14 1984-02-16 Hoechst Ag, 6230 Frankfurt Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Also Published As

Publication number Publication date
FR2548901A1 (fr) 1985-01-18
FI833742A (fi) 1984-12-24
DK476083A (da) 1984-12-24
ZA837673B (en) 1984-08-29
JPS6018765A (ja) 1985-01-30
AU2017183A (en) 1985-01-03
GB8317022D0 (en) 1983-07-27
NL8303571A (nl) 1985-01-16
SE8305667L (sv) 1984-12-24
NO833756L (no) 1984-12-27
BE899484A (fr) 1984-10-22
DK476083D0 (da) 1983-10-14
IT1194429B (it) 1988-09-22
IT8323351A0 (it) 1983-10-19
DE3337465A1 (de) 1985-01-03
FI833742A0 (fi) 1983-10-14

Similar Documents

Publication Publication Date Title
ATE6312T1 (de) Verfahren zur immunologischen bestimmung von basalmembranmaterial, hierfuer geeignete basalmembranfragmente und verfahren zu deren herstellung, bzw. gewinnung.
DE3382190D1 (de) Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff.
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
DE3586440D1 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
DK130791D0 (da) Monoklonale antistoffer, isaer for hb alc.
IL68941A0 (en) Method for immobilizing biological materials,composite materials produced thereby and their use
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
ATA208987A (de) Immortalisierte zellinie, verfahren zu ihrer herstellung und verfahren zur herstellung von monoklonalen antikörpern sowie diagnoseverfahren und -mittel
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
DK304087A (da) Humant monoklonalt antistof mod lumfadenopati-associeret virus
FI870502A0 (sv) Förfarande för framställning av korsskyddande humana monoklonala antikroppar och en cellinj som producerar antikropparna
NO830570L (no) Antistoffer og antigener for diagnose og behandling av cancer
DE3583875D1 (de) Verfahren zur herstellung von kugelfoermigen vollblut-erythrocyten und fixierung derselben.
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
EP0109434A4 (en) IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES.
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
DE3689868D1 (de) Monoklonale Antikörper gegen menschliches Plasma-Prekallikrein und Verfahren zu ihrer Herstellung und Verwendung.
SE8205891D0 (sv) Alfa-l-antikropp och sett for framstellning derav
SE8305667D0 (sv) Adenocarcinoma related new antigenic determinants and antibodies specific thereto, processes for their preparation and reagent systems pertaining to them
EP0307476A4 (en) Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
ES2059539T3 (es) Metodo para la prevencion de la enfermedad del injerto frente al huesped.
DE3682105D1 (de) Probe, tracers, immunogene und antikoerper von ethosuximid.
SE8403841D0 (sv) Blodtappningsvagga
EP0095502A4 (en) MONOCLONIC HUMAN ANTIBODIES OR LYMPHOCINS IN CELL SEPARATION OR IN DIAGNOSIS OF BREAST CANCER.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8305667-1

Effective date: 19870501